Literature DB >> 26510983

Socio-economic Aspects of Alzheimer's Disease.

Petra Marešová, Hana Mohelská, Josef Dolejš, Kamil Kuča1.   

Abstract

Social development, better living conditions and medical advances lead to the fact that more people have the opportunity to live longer than in the past. The aging population is a characteristic feature of demographic trends in developed countries. This trend is closely linked with the issue of increasing number of diseases in old age and increasing government expenditure on health and social care. The most frequently mentioned diseases in old age include dementia. The cause may lie in all kinds of diseases, the most common are Alzheimer's disease and cerebrovascular disease. Now the care of current 35 million patients with dementia costs over $ 600 billion per year, it is approximately one percent of global Gross Domestic Product. This review discusses the recent issues and questions in the area of social and economic aspects of Alzheimer's disease. It focuses in detail on the national strategies in the approach to Alzheimer's disease, the anticipated problems concerning the insufficient number of social workers and necessary expenses of state budgets in the future. The situation in the area of health insurance companies' expenditures is illustrated in the context of the analysis of long-term care systems, in the chosen countries within the European Union.

Entities:  

Mesh:

Year:  2015        PMID: 26510983     DOI: 10.2174/156720501209151019111448

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  31 in total

Review 1.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.

Authors:  Marcus O W Grimm; Daniel M Michaelson; Tobias Hartmann
Journal:  J Lipid Res       Date:  2017-05-20       Impact factor: 5.922

2.  The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.

Authors:  Petra Marešová; Veronika Zahálková
Journal:  Neurol Sci       Date:  2016-07-28       Impact factor: 3.307

3.  Drug discovery, development and delivery in Alzheimer's disease.

Authors:  Davide Brambilla
Journal:  Pharm Res       Date:  2017-12-29       Impact factor: 4.200

4.  The direct costs of multiple sclerosis-study in the Czech Republic.

Authors:  Petra Maresova; Martin Valis; Michal Novotny; Zbyšek Pavelek; Kamil Kuca
Journal:  Neurol Sci       Date:  2018-09-03       Impact factor: 3.307

5.  Detecting Anatomical Landmarks for Fast Alzheimer's Disease Diagnosis.

Authors:  Jun Zhang; Yue Gao; Yaozong Gao; Brent C Munsell; Dinggang Shen
Journal:  IEEE Trans Med Imaging       Date:  2016-06-20       Impact factor: 10.048

6.  Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease.

Authors:  Chandra Bhushan Mishra; Shruti Shalini; Siddharth Gusain; Amresh Prakash; Jyoti Kumari; Shikha Kumari; Anita Kumari Yadav; Andrew M Lynn; Manisha Tiwari
Journal:  RSC Adv       Date:  2020-05-05       Impact factor: 3.361

7.  Prediction of population with Alzheimer's disease in the European Union using a system dynamics model.

Authors:  Hana Tomaskova; Jitka Kuhnova; Richard Cimler; Ondrej Dolezal; Kamil Kuca
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-30       Impact factor: 2.570

8.  A Surgical Method to Improve the Homeostasis of CSF for the Treatment of Alzheimer's Disease.

Authors:  Yang Qin; Jian W Gu
Journal:  Front Aging Neurosci       Date:  2016-11-02       Impact factor: 5.750

9.  Treatment cost of narcolepsy with cataplexy in Central Europe.

Authors:  Petra Maresova; Michal Novotny; Blanka Klímová; Kamil Kuča
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

Review 10.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.